Follow
Herantis Pharma Oyj
Nasdaq First North Finland (Finland)
Nasdaq First North Sweden (Sweden)
Herantis Pharma PLC is a pharmaceutical drug development company. It focused on developing regenerative medicine for unmet clinical needs. The products of the group are CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, CDNF for Amyotrophic lateral sclerosis and CDNF for other neurodegenerative diseases. The corporation is based in Finland.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
HRNTS
FI4000087861
Nasdaq First North Sweden
Sweden (SE)
Details of share in Herantis Pharma Oyj with ticker HRNTS
Status
Active
Order book id
Amount of instruments
6 680 305
Par value
Market cap
Currency
SEK
Segment
First North
Terms
This share is the same as the one listed on First North Finland with ISIN FI4000087861.
Type
Price
Pre-money valuation
Time
New issue
71.00 SEK
18 Nov - 01 Dec 2019
Share issue in Herantis Pharma Oyj
Market
Nasdaq First North Sweden
Subscription period
18 Nov - 01 Dec 2019
Subscription price
71.00 SEK
Price per share
71.00 SEK
Target to raise
43 879 278 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
One part of the offer is directed to the public in Sweden and Denmark. Another part is a private placement to qualified investors and certain other investors in the European Economic Area. The offer is for 25.56 MSEK and and upsize option of 18.32 MSEK.
Comments for offer & related information
After this offer Herantis Pharma will also be listed on First North Sweden, as a secondary listing to the First North Finland listing.
Type
Price
Pre-money valuation
Time
Listing
-
16 Dec 2019
Direct listing of Herantis Pharma Oyj on Nasdaq First North Sweden
Market
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
Herantis Pharma is listed on First North Finland. In May 2019 the company said that they will also get listed on First North Sweden during 2019.

Update: Herantis Pharma is doing a public offer to investors in Sweden and Denmark, and a private placement. And the listing on First North Sweden is planned for 16 December 2019.
Type
Ticker
ISIN
Market
SHARE
HRTIS
FI4000087861
Nasdaq First North Finland
Finland (FI)
Details of share in Herantis Pharma Oyj with ticker HRTIS
Status
Active
Order book id
Amount of instruments
6 680 305
Par value
Market cap
Currency
EUR
Segment
Regular
Terms
People
Number of Employees
10 people
Pekka Ilmari Simula
CEO
Pekka Allan Antero Mattila
Chairman of the board
Pekka Allan Antero Mattila
Board member
James Neil Phillips
Board member
Timo Ilari Veromaa
Board member
Frans Gustaf Wuite
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
Bertel Jungin Aukio 1
Zip code
FI-02600
City/district
ESPOO
Country
Finland (FI)
Registration number
2198665-7
LEI code
743700W4CQVYAT3WKK38
First trade date
11 Jun 2014
Registration date
26 May 2008
Short name
Herantis Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More